Reply to E.J. Moylan et al

Affiliations

Comment

Sandra M Swain et al. J Clin Oncol. 2014.

. 2014 Feb 20;32(6):606-7.

doi: 10.1200/JCO.2013.53.8744. Epub 2014 Jan 13.

¹ National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA; and Medstar Washington Hospital Center, Washington, DC.

No abstract available

Comment on

Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial.
Swain SM, Tang G, Geyer CE Jr, Rastogi P, Atkins JN, Donnellan PP, Fehrenbacher L, Azar CA, Robidoux A, Polikoff JA, Brufsky AM, Biggs DD, Levine EA, Zapas JL, Provencher L, Northfelt DW, Paik S, Costantino JP, Mamounas EP, Wolmark N. Swain SM, et al. J Clin Oncol. 2013 Sep 10;31(26):3197-204. doi: 10.1200/JCO.2012.48.1275. Epub 2013 Aug 12. J Clin Oncol. 2013. PMID: 23940225 Free PMC article. Clinical Trial.
Are dose-dense and triplet chemotherapy regimens optimal adjuvant therapy in the majority of women with node-positive early breast cancer?
Moylan EJ, Connell LC, O'Reilly S. Moylan EJ, et al. J Clin Oncol. 2014 Feb 20;32(6):605-6. doi: 10.1200/JCO.2013.53.6771. Epub 2014 Jan 13. J Clin Oncol. 2014. PMID: 24419118 No abstract available.

1. Swain SM, Tang G, Geyer CE, Jr, et al. Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: The NSABP B-38 trial. J Clin Oncol. 2013;31:3197–3204. - PMC - PubMed
1. Moylan EJ, Connell LC, O'Reilly S. Are dose-dense and triplet chemotherapy regimens optimal adjuvant therapy in the majority of women with node-positive early breast cancer? J Clin Oncol. 2014;32:605–606. - PubMed
1. Bonilla L, Ben-Aharon I, Vidal L, et al. Dose-dense chemotherapy in nonmetastatic breast cancer: A systemic review and meta-analysis of randomized controlled trials. J Natl Cancer Inst. 2010;24:1845–1854. - PMC - PubMed
1. Perou CM, Sørlie T, Eisen MB, et al. Molecular portraits of human breast cancer. Nature. 2000;406:747–752. - PubMed
1. Paik S, Shak S, Tang G, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351:2817–2826. - PubMed